In this study, we present surface‐enhanced Raman spectroscopy (SERS) investigations for the erlotinib adsorbed onto silver nanoparticles (AgNPs). The observed spectral patterns, namely, changes in width and wavenumber of the SERS bands in comparison with these occurring in the corresponding Raman spectrum suggest how the investigated drug interacts with the applied metal nanoparticles. Moreover, the physicochemical investigations including transmission electron microscope, UV–Vis spectroscopy, and electrophoretic mobility measurements were used for characterization of the nanoparticles and erlotinib/nanoparticles stability. Briefly, the performed measurements suggest that the erlotinib strong interacts with the applied AgNPs. Additionally, the studied interaction seems to be the strongest for the acetylene moiety, which undergoes deprotonation. Also the –CNH and –OCH3 groups play an important role in the erlotinib–metal nanoparticles interaction. This is opposite for the CH2, which is only in certain distance from this nanosurface. In the case of the aromatic rings the two different ways of interaction were recognized. The phenyl ring interacts rather weak with the AgNPs and is oriented perpendicular onto the surface. Whereas, the quanizoline moiety only participates in this interaction with more or less tilted orientation with regards to the AgNPs. On the other hand, the SERS analysis for the different erlotinib concentration indicates that the discussed interaction is sensitive for the drug dilution.